Datta Sebak, M.Sc

University / Clinic: Innsbruck Medical University
Institute: Biocenter, Medical Biochemistry
 
Research Area: Breast Cancer, Signaling pathway

Email: sebak.datta@i-med.ac.at
Web: www.i-med.ac.at/imcbc/medclinchemfolder/medclinchem.html


Research Topic:
1)The role of STAT1 on doxorubicin induced myelosuppression and the function of STAT1 on B-cell maturation in the bone marrow.

2)Redundant and antagonistic functions of STAT1 and STAT3 in breast cancer. годжи ягоды


ягоды годжи цена



Selected publications:
 
  Tymoszuk P, Evens H, Marzola V, Wachowicz K, Wasmer M, Datta S, Müller-Holzner E, Fiegl H, Böck G, van Rooijen N, Theurl I, Doppler W
In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors.
Eur J Immunol. 2014 Aug;44(8):2247-62.

  Datta S, Parajuli N, Tymoszuk P, Ottina E, Parson W, Sgonc R, Villunger A, Doppler W
Replenishment of the B cell compartment after doxorubicin-induced hematopoietic toxicity is facilitated by STAT1.
J Leukoc Biol. 2014 Jun;95(6):853-66.

  Hannesdóttir L, Tymoszuk P, Parajuli N, Wasmer M, Philipp S, Daschil N, Datta S, Koller J, Tripp C, Stoitzner P, Müller-Holzner E, Wiegers G, Sexl V, Villunger A, Doppler W
Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response
Eur J Immunol. 2013 Jun 12